Medicare Enrolled

Dr. Rubaiya Mallay, D.O.

Rheumatology · Largo, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
13644 WALSINGHAM ROAD, Largo, FL 33774
7275952519
In practice since 2008 (17 years)
NPI: 1023268687 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mallay from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mallay? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mallay

Dr. Rubaiya Mallay is a rheumatology in Largo, FL, with 17 years in practice. Based on federal Medicare data, Dr. Mallay performed 2,255 Medicare services across 727 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mallay received a total of $251,356 from 66 pharmaceutical and/or device companies across 1966 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mallay is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice▲ 2,255 Medicare services$ $251,356 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,255
Medicare services
Bottom 40% in FL for rheumatology
727
Unique beneficiaries
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~133 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Manual therapy (hands-on treatment), per 15 min434$16$48
Office visit, established patient (30-39 min)406$88$140
Self-care/home management training, per 15 min255$21$55
Physical therapy exercise, per 15 min244$19$51
Office visit, established patient, complex (40-54 min)220$119$195
Drug injection, under skin or into muscle127$10$30
Injection, ketorolac tromethamine, per 15 mg122$0$10
Injection, methylprednisolone acetate, 40 mg76$6$10
Limited ultrasound scan of joint or other extremity structure except blood vessels66$33$53
Injection, methylprednisolone acetate, 80 mg62$8$20
Aspiration and/or injection of fluid large joint using ultrasound guidance46$74$110
X-ray of hand, minimum of 3 views37$26$55
X-ray of wrist, minimum of 3 views34$31$63
Office visit, established patient (20-29 min)34$62$100
Injection of trigger points, 3 or more muscles29$42$101
New patient office visit, complex (60-74 min)29$139$240
X-ray of knee, 1-2 views22$26$60
Evaluation for physical therapy, typically 30 minutes12$65$110
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$251,356
Total received (2018-2024)
Avg $35,908/year across 7 years
Top 5% in FL for rheumatology
66
Companies
1,966
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$225,611 (89.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,040 (8.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,705 (1.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$59,166
2023
$47,165
2022
$28,188
2021
$48,171
2020
$36,991
2019
$23,673
2018
$8,002

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$102,261
Horizon Therapeutics plc
$58,212
ABBVIE INC.
$41,452
AbbVie, Inc.
$10,929
AbbVie Inc.
$9,174
Amgen Inc.
$4,786
Janssen Biotech, Inc.
$4,088
Regeneron Healthcare Solutions, Inc.
$3,903
GlaxoSmithKline, LLC.
$2,762
UCB, Inc.
$2,199
PFIZER INC.
$1,827
Novartis Pharmaceuticals Corporation
$1,136
Genentech USA, Inc.
$1,057
Mallinckrodt Hospital Products Inc.
$906
Janssen Scientific Affairs, LLC
$731
Radius Health, Inc.
$574
Boehringer Ingelheim Pharmaceuticals, Inc.
$539
E.R. Squibb & Sons, L.L.C.
$503
Lilly USA, LLC
$451
SANOFI-AVENTIS U.S. LLC
$424
Novo Nordisk Inc
$304
Mallinckrodt Enterprises LLC
$276
Actelion Pharmaceuticals US, Inc.
$264
Fresenius Kabi USA, LLC
$213
Celgene Corporation
$195
Aurinia Pharma U.S., Inc.
$180
AstraZeneca Pharmaceuticals LP
$170
Horizon Pharma plc
$157
Allergan, Inc.
$157
Kiniksa Pharmaceuticals, Ltd.
$145
Bayer HealthCare Pharmaceuticals Inc.
$132
Mallinckrodt LLC
$110
Allergan Inc.
$110
Antares Pharma, Inc.
$70
IDORSIA PHARMACEUTICALS US INC
$66
Bayer Healthcare Pharmaceuticals Inc.
$59
Amarin Pharma Inc.
$58
Abbott Laboratories
$57
Janssen Pharmaceuticals, Inc
$57
Boston Scientific Corporation
$54
GRT US Holding, Inc.
$50
Fidia Pharma USA Inc.
$42
Johnson & Johnson Health Care Systems Inc.
$40
Eisai Inc.
$39
Ultragenyx Pharmaceutical Inc.
$35
Pharming Healthcare, Inc.
$33
Shire North American Group Inc
$31
Organon LLC
$29
Purdue Pharma L.P.
$25
AMAG Pharmaceuticals, Inc.
$24
Astellas Pharma US Inc
$24
Renalytix AI, Inc.
$22
DePuy Synthes Sales Inc.
$22
JAZZ PHARMACEUTICALS INC.
$19
Organon Llc
$18
Flexion Therapeutics, Inc.
$17
Kiniksa Pharmaceuticals International, plc
$17
Dexcom, Inc.
$16
Synergy Pharmaceuticals Inc
$16
Takeda Pharmaceuticals U.S.A., Inc.
$14
Daiichi Sankyo Inc.
$14
Merck Sharp & Dohme Corporation
$14
SOBI, INC
$13
Sanofi Pasteur Inc.
$12
SANOFI PASTEUR INC.
$11
MEDEXUS PHARMA, INC.
$11
Top 3 companies account for 80.3% of total payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AREXVY · AVSOLA · Actemra · Aimovig · Arcalyst · BENLYSTA · BOTOX · BOTOX THERAPEUTIC · Bimzelx · CINRYZE · COSENTYX · CUVITRU · CYLTEZO · Cimzia · Crysvita · DUEXIS · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMBEDA · EVENITY · EVUSHELD · Enbrel · FERAHEME · FLUBLOK QUADRIVALENT · FLUZONE HIGH-DOSE · FREESTYLE LIBRE 3 · GENERAL - VASCULAR INTERVENTION · HADLIMA · HUMIRA · HYM/HYN · HYMOVIS · Humira · IDACIO · INFLECTRA · INJECTAFER · KEVZARA · KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT · KINERET · KRYSTEXXA · Kerendia · LEQVIO · LUPKYNIS · LYRICA · MONOVISC · MOUNJARO · MYRBETRIQ · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OLUMIANT · OPSUMIT · OPSUMIT MACITENTAN · ORENCIA · Otezla · Otrexup · Ozempic · PAXLOVID · PENNSAID · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PROCLAIM · Prolia · QULIPTA · QUVIVIQ · Qutenza · RAYOS · REMICADE · RENFLEXIS · RINVOQ · RUCONEST · Rasuvo · Rinvoq · Rituxan · Rybelsus · SAPHNELO · SHINGRIX · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STIOLTO RESPIMAT · SUNOSI · SYMPROIC · TAKHZYRO · TALTZ · TAVNEOS · TEPEZZA · TRELEGY ELLIPTA · TREMFYA · Tavneos · Trulance · Tyenne · Tymlos · UBRELVY · UPTRAVI · Vascepa · WATCHMAN Access System · XARELTO · XELJANZ · Xolair · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for rheumatology in FL.

Equivalent to $11,147 per 100 Medicare services performed
Looking for a rheumatology in Largo?
Compare rheumatologys in the Largo area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
40
Per 100K population
4.2
County median income
$70,293
Nearest hospital
HCA FLORIDA LARGO HOSPITAL
2.6 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Mallay is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 5%), with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Mallay experienced with manual therapy (hands-on treatment), per 15 min?
Based on Medicare claims data, Dr. Mallay performed 434 manual therapy (hands-on treatment), per 15 min services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mallay receive payments from pharmaceutical companies?
Yes. Dr. Mallay received a total of $251,356 from 66 companies across 1,966 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mallay's costs compare to other rheumatologys in Largo?
Dr. Mallay's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mallay) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →